Vimovo

Toothache, Chronic Pain, Migraine + 24 more
Treatment
11 FDA approvals
20 Active Studies for Vimovo

What is Vimovo

NaproxenThe Generic name of this drug
Treatment SummaryEsomeprazole, commonly known by its brand name Nexium, is a medication that reduces the amount of acid produced in the stomach. It is used to treat gastroesophageal reflux disease (GERD), stomach ulcers, and other conditions related to overproduction of stomach acid. It can also be prescribed in quadruple regimens to treat infections caused by the bacteria H. pylori. Esomeprazole is similar to other proton pump inhibitors (PPIs) such as omeprazole, lansoprazole, pantoprazole and rabeprazole. It works by binding
Naprosynis the brand name
image of different drug pills on a surface
Vimovo Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Naprosyn
Naproxen
1976
1260

Approved as Treatment by the FDA

Naproxen, otherwise known as Naprosyn, is approved by the FDA for 11 uses including Inflammation and Toothache .
Inflammation
Used to treat articular inflammation in combination with Esomeprazole
Toothache
Menstrual Distress (Dysmenorrhea)
Ankylosing Spondylitis
Used to treat Ankylosing Spondylitis (AS) in combination with Esomeprazole
Acute Coryza
Used to treat Acute Migraine in combination with Sumatriptan
Osteoarthritis (OA)
Used to treat Osteoarthritis (OA) in combination with Esomeprazole
Rheumatoid Arthritis
Used to treat Rheumatoid Arthritis in combination with Esomeprazole
Back
Migraine
Juvenile arthritis
Used to treat Juvenile Idiopathic Arthritis (JIA) in combination with Esomeprazole
Fever

Effectiveness

How Vimovo Affects PatientsEsomeprazole is a drug used to treat Gastroesophageal Reflux Disease (GERD), erosive esophagitis, and prevent duodenal ulcer recurrence. It works by blocking the enzyme in the stomach that produces acid. This reduces the amount of acid in the stomach, preventing symptoms of GERD and protecting the stomach from ulcers. Esomeprazole is similar to other drugs in its class, but it does not have anticholinergic or antihistamine side effects. Taking esomeprazole long-term can be associated with potential risks,
How Vimovo works in the bodyEsomeprazole is used to reduce the amount of stomach acid produced. It does this by binding to proteins on the surface of cells in the stomach, called (H+, K+)-ATPase enzymes. This binding prevents the last step in the production of stomach acid and reduces both the normal and extra production that can occur due to triggers like stress or spicy foods. The binding of esomeprazole to the (H+, K+)-ATPase enzyme is permanent, so the effects can last for more than 24 hours.

When to interrupt dosage

The advisable amount of Vimovo is contingent upon the diagnosed circumstance, including Curling Ulcer, Hemorrhage and Critical Illness. The magnitude of dosage differs, as per the approach of delivery (e.g. Tablet, delayed release or Injection, powder, lyophilized, for solution - Intravenous) denoted in the table beneath.
Condition
Dosage
Administration
Migraine
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
prophylaxis of migraine headaches
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Rheumatoid Arthritis, Juvenile
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Collagen Diseases
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Nasal Congestion
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Bursitis
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Acute Coryza
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Juvenile arthritis
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Hay Fever
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Osteoarthritis (OA)
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Rheumatoid Arthritis
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Post Traumatic Pain
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Inflammation
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Ankylosing Spondylitis
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Primary Dysmenorrhoea
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Toothache
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Chronic Pain
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Migraine
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Sinusitis
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Influenza
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical

Warnings

Vimovo Contraindications
Condition
Risk Level
Notes
Coronary Artery Bypass Grafting
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Naproxen may interact with Pulse Frequency
Severe Hypersensitivity Reactions
Do Not Combine
Naproxen may interact with Pulse Frequency
Severe Hypersensitivity Reactions
Do Not Combine
Naproxen may interact with Pulse Frequency
There are 20 known major drug interactions with Vimovo.
Common Vimovo Drug Interactions
Drug Name
Risk Level
Description
Amiodarone
Major
The metabolism of Amiodarone can be decreased when combined with Naproxen.
Brigatinib
Major
The metabolism of Brigatinib can be decreased when combined with Naproxen.
Cabazitaxel
Major
The metabolism of Cabazitaxel can be decreased when combined with Naproxen.
Enasidenib
Major
The metabolism of Enasidenib can be decreased when combined with Naproxen.
Erlotinib
Major
The metabolism of Erlotinib can be decreased when combined with Naproxen.
Vimovo Toxicity & Overdose RiskCommon side effects of overdoses on this drug include blurry vision, confusion, tiredness, dry mouth, feeling flushed, headaches, nausea, a rapid heartbeat, and sweating.
image of a doctor in a lab doing drug, clinical research

Vimovo Novel Uses: Which Conditions Have a Clinical Trial Featuring Vimovo?

26 active clinical trials are currently assessing the utility of Vimovo in addressing previous gastric or duodenal ulcer, Stomach Ulcer and Peptic Ulcer.
Condition
Clinical Trials
Trial Phases
Chronic Pain
174 Actively Recruiting
Phase 2, Phase 3, Not Applicable, Phase 1, Phase 4, Early Phase 1
Rheumatoid Arthritis
61 Actively Recruiting
Not Applicable, Phase 4, Phase 3, Phase 2, Phase 1
Migraine
53 Actively Recruiting
Not Applicable, Phase 3, Phase 2, Phase 1, Phase 4, Early Phase 1
Rheumatoid Arthritis, Juvenile
4 Actively Recruiting
Not Applicable, Phase 3
Sinusitis
19 Actively Recruiting
Not Applicable, Early Phase 1, Phase 2, Phase 3, Phase 4
prophylaxis of migraine headaches
0 Actively Recruiting
Toothache
1 Actively Recruiting
Phase 3
Muscle Spasms
0 Actively Recruiting
Acute Coryza
0 Actively Recruiting
Ankylosing Spondylitis
2 Actively Recruiting
Phase 3, Not Applicable
Primary Dysmenorrhoea
2 Actively Recruiting
Phase 4, Not Applicable
Hay Fever
1 Actively Recruiting
Phase 3
Osteoarthritis (OA)
0 Actively Recruiting
Post Traumatic Pain
0 Actively Recruiting
Migraine
52 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Phase 3, Phase 4, Early Phase 1
Influenza
32 Actively Recruiting
Not Applicable, Phase 2, Phase 4, Phase 3, Phase 1
Tendinitis
1 Actively Recruiting
Not Applicable
Nasal Congestion
1 Actively Recruiting
Not Applicable
Fever
18 Actively Recruiting
Phase 3, Phase 4, Phase 2, Phase 1, Not Applicable
Inflammation
0 Actively Recruiting

Vimovo Reviews: What are patients saying about Vimovo?

5Patient Review
12/29/2019
Vimovo for Osteoarthritis and High Risk of Developing Gastric Ulcers
I don't understand why people are so uneducated about their medications. Naprosyn Sodium is the same drug as Alleve, and the side effects come from IT. The other drug is simply to try to reduce the harsh effects of Naprosyn Sodium on your G I tract. It's not a separate medication, but a combination of two drugs.
5Patient Review
10/4/2016
Vimovo for Osteoarthritis and High Risk of Developing Gastric Ulcers
I've been taking this treatment for around a week to help with my hip pain. While it does work well, I have noticed some concerning side effects like dizziness and heart palpitations. Not sure if I'll be able to take it long-term.
4Patient Review
11/2/2016
Vimovo for Osteoarthritis and High Risk of Developing Gastric Ulcers
Vimovo has done wonders for my arthritis pain. I was previously taking four Aleve pills per day, plus four Nexium pills (all over the counter at the recommended dosage), but now I only need to take two Vimovo pills and I'm good to go. No more stomach burn or nausea, and a lot fewer pills!
3.7Patient Review
4/17/2018
Vimovo for Osteoarthritis and High Risk of Developing Gastric Ulcers
I started taking Vimovo because I developed ulcers from Naproxin. I was on it for over a year, and only realized how much it impacted my mood once I stopped taking it. It did help with my Fibro pain and back issues, but the cost was too high.
3.7Patient Review
3/20/2019
Vimovo for Osteoarthritis and High Risk of Developing Gastric Ulcers
Worked well until an unfortunate side effect developed.
3Patient Review
10/16/2015
Vimovo for Rheumatoid Arthritis and High Risk of Developing Gastric Ulcers
I was prescribed this for an infection in my jaw that caused it to click when I opened my mouth. After four days of taking the medication as directed, I experienced extreme drowsiness, muscle pain, headaches, and neck pain. I also had trouble eating and felt nauseous most of the time. This was by far the worst experience I've ever had with a medication and would not recommend it to anyone.
2.3Patient Review
5/7/2018
Vimovo for Osteoarthritis and High Risk of Developing Gastric Ulcers
I've been struggling with Achilles tendinitis for over half a year now and have tried many different treatments to no avail. My doctor prescribed Vimovo, but after taking it I experienced severe pain in my abdomen and was unable to sleep. I'll be discontinuing use of this medication and instead stick to Advil and Turmeric.
2.3Patient Review
4/9/2019
Vimovo for Osteoarthritis and High Risk of Developing Gastric Ulcers
Unfortunately, this treatment gave me really severe diarrhea and stomach pain. It also killed my appetite. I had to stop taking it after a month.
2Patient Review
9/24/2015
Vimovo for Ankylosing Spondylitis and High Risk of Developing Gastric Ulcers
2Patient Review
1/21/2020
Vimovo for Rheumatoid Arthritis and High Risk of Developing Gastric Ulcers
I was prescribed this medication to help with my rheumatoid arthritis. Unfortunately, I saw zero difference after taking it as directed; might as well have eaten Smarties.
1Patient Review
8/28/2017
Vimovo for Rheumatoid Arthritis and High Risk of Developing Gastric Ulcers
I had such terrible reactions to this medicine- vomiting, diarrhea, and numbness in my extremities. I think it might have also been causing problems with my liver or gallbladder because I was vomiting green bile.
1Patient Review
5/12/2019
Vimovo for Osteoarthritis and High Risk of Developing Gastric Ulcers
While this medication did help my arthritis pain, it also caused severe and permanent damage to the lining of my stomach after just six months. I had to be hospitalized as a result and was diagnosed with chronic microscopic colitis. If there were any way to take legal action against the manufacturer of this drug, I would.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about vimovo

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

When should I take vimovo?

"Vimovo is typically taken twice per day, at least 30 minutes before a meal. Follow directions on the prescription label and read all medication guides or instruction sheets. Use the medicine as directed. Swallow the tablet whole and do not crush, chew, or break it."

Answered by AI

Is vimovo the same as ibuprofen?

"The drugs Vimovo and Ibuprofen both contain NSAIDs. Vimovo also contains a proton pump inhibitor. There are various brand names for ibuprofen, such as Advil and Motrin. Motrin (Ibuprofen) can be bought OTC or as a generic."

Answered by AI

What is vimovo pills used for?

"This medication falls under the NSAID category and is used to treat various forms of arthritis. The active ingredients in this medication are esomeprazole and naproxen. This medication carries a high risk for stomach bleeding and ulcers, and should be used with caution in patients with a history of gastric ulcers."

Answered by AI

Is vimovo a painkiller?

"Esomeprazole is a medicine that reduces the amount of acid produced in your stomach.

If you are suffering from pain and need an anti-inflammatory painkiller, Vimovo may be a good option for you as it also provides stomach protection. Vimovo 500mg/20mg modified release tablets contain naproxen and esomeprazole as active ingredients. Naproxen is a powerful anti-inflammatory painkiller (also known as an NSAID) that can be used to treat various painful conditions. Esomeprazole is a medicine designed to reduce the amount of acid produced in your stomach."

Answered by AI

Clinical Trials for Vimovo

Have you considered Vimovo clinical trials? We made a collection of clinical trials featuring Vimovo, we think they might fit your search criteria.
Have you considered Vimovo clinical trials? We made a collection of clinical trials featuring Vimovo, we think they might fit your search criteria.
Have you considered Vimovo clinical trials? We made a collection of clinical trials featuring Vimovo, we think they might fit your search criteria.